The Medicines Co (The Medicines Co) Total Assets : $897.27 Mil (As of Sep. 2019)

View and export this data going back to 2000. Start your Free Trial

What is The Medicines Co Total Assets?

The Medicines Co's Total Assets for the quarter that ended in Sep. 2019 was $897.27 Mil.

Total Assets is connected with ROA %. The Medicines Co's annualized ROA % for the quarter that ended in Sep. 2019 was -31.94%. Total Assets is also linked to Revenue through Asset Turnover. The Medicines Co's Asset Turnover for the quarter that ended in Sep. 2019 was 0.00.

The Medicines Co Total Assets Historical Data

The historical data trend for The Medicines Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Medicines Co Total Assets Chart

The Medicines Co Annual Data

Trend

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Total Assets

Get a 7-Day Free Trial

1,885.71

1,795.52

1,705.21

872.98

841.69

The Medicines Co Quarterly Data
	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19
Total Assets	Get a 7-Day Free Trial															733.74	841.69	835.85	956.27	897.27

The Medicines Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

The Medicines Co's Total Assets for the fiscal year that ended in Dec. 2018 is calculated as

Total Assets	=	Total Equity (A: Dec. 2018 )	+	Total Liabilities (A: Dec. 2018 )
	=	-22.264	+	863.95
	=	841.69

The Medicines Co's Total Assets for the quarter that ended in Sep. 2019 is calculated as

Total Assets	=	Total Equity (Q: Sep. 2019 )	+	Total Liabilities (Q: Sep. 2019 )
	=	-26.003	+	923.273
	=	897.27

The Medicines Co (NAS:MDCO) Total Assets Explanation

Total Assets is connected with ROA %.

The Medicines Co's annualized ROA % for the quarter that ended in Sep. 2019 is

ROA %	=	Net Income (Q: Sep. 2019 )	/	( (Total Assets (Q: Jun. 2019 )	+	Total Assets (Q: Sep. 2019 ))	/ count )
	=	-295.976	/	( (956.273	+	897.27)	/ 2 )
	=	-295.976	/	926.7715
	=	-31.94 %

Note: The Net Income data used here is four times the quarterly (Sep. 2019) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

The Medicines Co's Asset Turnover for the quarter that ended in Sep. 2019 is

	Asset Turnover
=	Revenue (Q: Sep. 2019 )	/	( (Total Assets (Q: Jun. 2019 )	+	Total Assets (Q: Sep. 2019 ))	/ count )
=	0	/	( (956.273	+	897.27)	/ 2 )
=	0	/	926.7715
=	0.00

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

The Medicines Co Total Assets Related Terms

Thank you for viewing the detailed overview of The Medicines Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

The Medicines Co (The Medicines Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » The Medicines Co (NAS:MDCO) » Definitions » Total Assets

Traded in Other Exchanges

N/A

Address

8 Sylvan Way, Parsippany, NJ, USA, 07054

Website

https://www.themedicinescompany.com

The Medicines Company is a pharmaceutical firm that provides products to the U.S. hospital market. The company's primary commercial product, Angiomax, is an anticoagulant drug used in conjunction with aspirin for patients undergoing angioplasty. Medicines recently commercialized a new drug, Cleviprex, which is designed to control blood pressure in intensive-care settings.

Executives

Alexander J Denner	director	C/O SARISSA CAPITAL MANAGEMENT LP, 660 STEAMBOAT ROAD, 3RD FLOOR, GREENWICH CT 06830
Peter Wijngaard	officer: Chief Development Officer	8 SYLVAN WAY, PARSIPPANY NJ 07054
Paris Panayiotopoulos	director	ARIAD PHARMACEUTICALS, INC., 26 LANDSDOWNE STREET, CAMBRIDGE MA 02139
Geno J Germano	director	5 GIRALDA FARMS, MADISON NJ 07940
Sarah J. Schlesinger	director	C/O ARIAD PHARMACEUTICALS, 26 LANDSDOWNE STREET, CAMBRIDGE MA 02139
Christopher T Cox	officer: EVP & Chief Corp. Dev. Officer	CADWALADER, WICKERSHAM & TAFT LLP, ONE WORLD FINANCIAL CENTER, NEW YORK NY 10281
Fredric N Eshelman	director, officer: Executive Chairman	PPD INC, 929 NORTH FRONT STREET, WILMINGTON NC 28401
Armin M Kessler	director
Robert J Hugin	director	C/O THE MEDICINES CO, 8 CAMPUS DR, PARSIPPANY NJ 07054
Hiroaki Shigeta	director	THE MEDICINES COMPANY, 8 SYLVAN WAY, PARSIPPANY NJ 07054
Stuart A Kingsley	officer: President and COO	152 CHESTNUT STREET, WEST NEWTON MA 02465
Robert G. Savage	director	C/O EPICEPT CORPORATION, 777 OLD SAW MILL ROAD, TARRYTOWN NY 10591
Glenn Sblendorio	director, officer: President & CFO	3 TIMES SQAURE, 12TH FLOOR, NEW YORK NY 10036
James E Flynn	10 percent owner, other: Possible Members of 10% Group	780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017
Deerfield Management Company, L.p. (series C)	10 percent owner, other: Possible Members of 10% Group	345 PARK AVENUE SOUTH, 12TH FLOOR, NEW YORK NY 10010